Product overview

Name MOG (35-55)
Purity >95%
Description Myelin oligodendrocyte glycoprotein fragment. Induces experimental multiple sclerosis-like disease.
Write Your Own Review
You're reviewing:MOG (35-55)
Rate this item:

Biological Data

Biological description

Myelin oligodendrocyte glycoprotein fragment which is a component of CNS myelin. Induces experimental multiple sclerosis-like disease and induces T-cell mediated multiple sclerosis models. Also induces tolerogenic dendritic cells and supresses disease development in multiple sclerosis models when co-administered with ITE.

Solubility & Handling

Storage instructions -20°C
Solubility overview Soluble in water (1 mg/ml)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >95%
Molecular Weight 2581.97
Molecular Formula C118H177N35O29S
CAS Number 149635-73-4
PubChem identifier 24868190
Source Synthetic
InChiKey JMTCEFUSRHYJBF-DDJPMISGSA-N
Appearance White solid

References for MOG (35-55)

References are publications that support the biological activity of the product
  • Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

    Haas J et al (2005) European journal of immunology 35 : 3343-52
  • Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.

    Oliver AR et al (2003) Journal of immunology (Baltimore, Md. : 1950) 171 : 462-8

2 Item(s)